Eucrates Biomedical Acquisition (EUCRU) Stock Price, News & Analysis

Company Overview

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Key Stats

• Today's Range: $10.01 to $10.02
• 50-Day Range: $10.02 to $10.02
• 52-Week Range: $9.76 to $10.66
• Volume: 21,500 shs
• Average Volume: 1,921 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EUCRU Stock Analysis - Frequently Asked Questions

How have EUCRU shares performed this year?

Eucrates Biomedical Acquisition's stock was trading at $10.02 at the beginning of 2025. Since then, EUCRU stock has increased by 0.0% and is now trading at $10.02.

How do I buy shares of Eucrates Biomedical Acquisition?

Shares of EUCRU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Finance
• Industry: Shell Companies
• Sub-Industry: Trading
• Current Symbol: OTCMKTS:EUCRU
• CIK: 1822929
• Web: N/A
• Phone: (212) 710-5220
• Fax: N/A
• Employees: 4
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A